GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0016049110 | Esophagus | ESCC | cell growth | 289/8552 | 482/18723 | 1.29e-10 | 3.77e-09 | 289 |
GO:003070518 | Esophagus | ESCC | cytoskeleton-dependent intracellular transport | 133/8552 | 195/18723 | 1.48e-10 | 4.27e-09 | 133 |
GO:001097013 | Esophagus | ESCC | transport along microtubule | 107/8552 | 155/18723 | 3.17e-09 | 6.80e-08 | 107 |
GO:000808810 | Esophagus | ESCC | axo-dendritic transport | 58/8552 | 75/18723 | 2.09e-08 | 4.02e-07 | 58 |
GO:00989304 | Esophagus | ESCC | axonal transport | 49/8552 | 64/18723 | 4.54e-07 | 6.15e-06 | 49 |
GO:00991114 | Esophagus | ESCC | microtubule-based transport | 115/8552 | 190/18723 | 2.54e-05 | 2.15e-04 | 115 |
GO:000689818 | Esophagus | ESCC | receptor-mediated endocytosis | 142/8552 | 244/18723 | 5.22e-05 | 4.05e-04 | 142 |
GO:199009017 | Esophagus | ESCC | cellular response to nerve growth factor stimulus | 38/8552 | 53/18723 | 1.10e-04 | 7.69e-04 | 38 |
GO:199008916 | Esophagus | ESCC | response to nerve growth factor | 39/8552 | 56/18723 | 2.44e-04 | 1.51e-03 | 39 |
GO:006056010 | Esophagus | ESCC | developmental growth involved in morphogenesis | 131/8552 | 234/18723 | 9.28e-04 | 4.73e-03 | 131 |
GO:00215436 | Esophagus | ESCC | pallium development | 94/8552 | 169/18723 | 5.79e-03 | 2.14e-02 | 94 |
GO:004858810 | Esophagus | ESCC | developmental cell growth | 125/8552 | 234/18723 | 1.01e-02 | 3.46e-02 | 125 |
GO:0048011 | Esophagus | ESCC | neurotrophin TRK receptor signaling pathway | 17/8552 | 24/18723 | 1.13e-02 | 3.81e-02 | 17 |
GO:006056012 | Lung | AIS | developmental growth involved in morphogenesis | 51/1849 | 234/18723 | 4.43e-08 | 5.24e-06 | 51 |
GO:001604912 | Lung | AIS | cell growth | 83/1849 | 482/18723 | 3.26e-07 | 2.79e-05 | 83 |
GO:000689812 | Lung | AIS | receptor-mediated endocytosis | 50/1849 | 244/18723 | 4.47e-07 | 3.52e-05 | 50 |
GO:199013812 | Lung | AIS | neuron projection extension | 38/1849 | 172/18723 | 1.57e-06 | 9.85e-05 | 38 |
GO:004858812 | Lung | AIS | developmental cell growth | 47/1849 | 234/18723 | 1.77e-06 | 1.05e-04 | 47 |
GO:003070512 | Lung | AIS | cytoskeleton-dependent intracellular transport | 37/1849 | 195/18723 | 7.68e-05 | 1.95e-03 | 37 |
GO:009917311 | Lung | AIS | postsynapse organization | 31/1849 | 168/18723 | 4.67e-04 | 7.79e-03 | 31 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TMEM108 | SNV | Missense_Mutation | | c.143N>A | p.Gly48Glu | p.G48E | Q6UXF1 | protein_coding | deleterious_low_confidence(0.01) | benign(0.088) | TCGA-A2-A0EO-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD |
TMEM108 | SNV | Missense_Mutation | novel | c.1567G>C | p.Glu523Gln | p.E523Q | Q6UXF1 | protein_coding | deleterious(0.03) | probably_damaging(0.998) | TCGA-C8-A12T-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TMEM108 | insertion | Nonsense_Mutation | novel | c.287_288insATAACTAGAAATGTTTTTAAA | p.Thr96_Ile97insTer | p.T96_I97ins* | Q6UXF1 | protein_coding | | | TCGA-B6-A0IA-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TMEM108 | SNV | Missense_Mutation | | c.1603N>C | p.Glu535Gln | p.E535Q | Q6UXF1 | protein_coding | tolerated(0.05) | probably_damaging(0.952) | TCGA-C5-A1BQ-01 | Cervix | cervical & endocervical cancer | Female | >=65 | III/IV | Chemotherapy | cisplatin | CR |
TMEM108 | SNV | Missense_Mutation | | c.1196N>A | p.Gly399Glu | p.G399E | Q6UXF1 | protein_coding | tolerated_low_confidence(0.9) | benign(0.01) | TCGA-EK-A2RJ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
TMEM108 | SNV | Missense_Mutation | novel | c.1230N>A | p.Met410Ile | p.M410I | Q6UXF1 | protein_coding | tolerated_low_confidence(0.37) | benign(0.006) | TCGA-IR-A3LH-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
TMEM108 | SNV | Missense_Mutation | | c.1279N>A | p.Gly427Ser | p.G427S | Q6UXF1 | protein_coding | deleterious(0) | probably_damaging(0.977) | TCGA-A6-2686-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TMEM108 | SNV | Missense_Mutation | rs199967106 | c.476G>A | p.Arg159His | p.R159H | Q6UXF1 | protein_coding | deleterious_low_confidence(0.01) | benign(0.386) | TCGA-AA-3685-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
TMEM108 | SNV | Missense_Mutation | rs761644701 | c.1625G>A | p.Arg542His | p.R542H | Q6UXF1 | protein_coding | deleterious(0.01) | benign(0.236) | TCGA-AA-3989-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | PD |
TMEM108 | SNV | Missense_Mutation | novel | c.433N>G | p.Lys145Glu | p.K145E | Q6UXF1 | protein_coding | tolerated_low_confidence(0.06) | benign(0.003) | TCGA-G4-6295-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |